Arvaya Healthcare receives BSE in-principle approval for preferential issue
FUNDRAISE
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 12 Oct 2026, 06:42 PM IST · BSE ID: 44b411dc-86e3-4c55-9c2b-0eebc904ebb3
View Original BSE Filing (PDF)
💡
In Simple Terms
The stock exchange has given initial approval for the company to issue new shares to specific investors at a set price.
🤖 AI Summary
- BSE grants in-principle approval for Arvaya Healthcare's preferential issue of 38,71,854 equity shares.
- Shares will be issued at Rs. 40 each, totaling an issue price of Rs. 154,874,160.
- Approval received on October 12, 2026, is for a preferential allotment of equity.
- This follows earlier board decisions to approve a preferential allotment and a rights issue.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares
38,71,854
Issue Price per Equity Share
Rs. 40/-
Total Issue Value
Rs. 154,874,160
🏢 How This Affects the Company
This approval is a step towards finalizing the preferential allotment, which could fund ongoing corporate activities or strategic initiatives.
The preferential issue will raise capital, increasing the company's equity base and cash reserves at the specified issue price.
The successful completion of the preferential issue is subject to final regulatory clearances and investor participation.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this specific preferential allotment approval.
👤
Who Is Affected
The preferential allotment will affect all existing shareholders through potential dilution of their existing shareholding percentage.
🔍
Management Signal
Management is actively pursuing capital raise initiatives, indicated by pursuing preferential allotment and a prior rights issue plan.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Final BSE approval for preferential allotment.
Confirmation of completion of preferential issue.
Disclosure of funds utilization from the issue.
MEDIUM RISK
Regulatory approvals are subject to final confirmation, and completion depends on subscriber commitment.
💡 Investor Takeaway
Arvaya Healthcare received BSE in-principle approval for a preferential issue of 38,71,854 equity shares at Rs. 40 each, raising Rs. 154,874,160.
⚖️ Strengths & Concerns
✅ Positives
- BSE in-principle approval received for preferential issue of 38,71,854 equity shares at Rs. 40 per share.
📅 Company Track Record
Previously, Arvaya Healthcare's board approved a preferential allotment, a Rs. 15.49 Cr acquisition, and planned a Rs. 210 Cr rights issue.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the total value of Arvaya Healthcare's preferential share issue?
The preferential issue is for 38,71,854 equity shares at Rs. 40 each, totaling Rs. 154,874,160.
When did Arvaya Healthcare receive in-principle approval from BSE?
Arvaya Healthcare received the in-principle approval from BSE on October 12, 2026.
How many shares will Arvaya Healthcare issue on a preferential basis?
Arvaya Healthcare will issue 38,71,854 equity shares on a preferential basis.
What is the price per share for Arvaya Healthcare's preferential issue?
The issue price for the preferential allotment is Rs. 40 per equity share.
Questions based on this BSE filing only. For information purposes.